1. Home
  2. NVRI vs PGEN Comparison

NVRI vs PGEN Comparison

Compare NVRI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enviri Corporation

NVRI

Enviri Corporation

N/A

Current Price

$17.97

Market Cap

1.5B

Sector

Miscellaneous

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$3.52

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NVRI
PGEN
Founded
1853
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
NVRI
PGEN
Price
$17.97
$3.52
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.67
AVG Volume (30 Days)
1.3M
4.7M
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,240,358,000.00
$230,981,000.00
Revenue This Year
N/A
$342.78
Revenue Next Year
$3.12
$478.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$1.11
52 Week High
$19.48
$5.47

Technical Indicators

Market Signals
Indicator
NVRI
PGEN
Relative Strength Index (RSI) 44.37 38.32
Support Level $17.86 $3.49
Resistance Level $18.62 $5.10
Average True Range (ATR) 0.61 0.29
MACD -0.12 -0.09
Stochastic Oscillator 44.71 14.68

Price Performance

Historical Comparison
NVRI
PGEN

About NVRI Enviri Corporation

Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: